Therapeutic abortion of early human gestation with intramuscular 15-methyl prostaglandin F2α
- 31 March 1976
- journal article
- Published by Elsevier in Contraception
- Vol. 13 (3) , 319-332
- https://doi.org/10.1016/s0010-7824(76)80042-x
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Efficacy and acceptability of 15(S)-15-methyl-prostaglandin E2-methyl ester for midtrimester pregnancy terminationAmerican Journal of Obstetrics and Gynecology, 1974
- Abortifacient action of orally administered 16, 16 dimethyl prostaglandin E2 and its methyl esterProstaglandins, 1974
- Therapeutic abortion of early human gestation with vaginal suppositories of prostaglandin F2αAmerican Journal of Obstetrics and Gynecology, 1973
- Regulation of Human Gonadotropins. VIII. Suppression of Serum LH and FSH in Adult Males following Exogenous Testosterone AdministrationJournal of Clinical Endocrinology & Metabolism, 1972
- Simultaneous Measurement of Plasma Progesterone, 17-Hydroxyprogesterone and Estradiol-17B by RadioimmunoassayAnalytical Letters, 1971
- Radioimmunoassay of Plasma ProgesteroneJournal of Clinical Endocrinology & Metabolism, 1971
- THERAPEUTIC ABORTION AND INDUCTION OF LABOUR BY THE INTRAVAGINAL ADMINISTRATION OF PROSTAGLANDINS E2 AND F2αBJOG: An International Journal of Obstetrics and Gynaecology, 1971
- THERAPEUTIC ABORTION USING PROSTAGLANDIN F2αThe Lancet, 1970